Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]
Thrombolysis and mechanical thrombectomy have revolutionized the care of patients with acute ischemic stroke. The number of patients who can benefit from these treatments continues to increase as new studies demonstrate that not just time since stroke onset but also collateral circulation influences...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-06-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-546/v1 |
id |
doaj-f2f6a59090e8429e8f93c6a466054993 |
---|---|
record_format |
Article |
spelling |
doaj-f2f6a59090e8429e8f93c6a4660549932020-11-25T03:56:13ZengF1000 Research LtdF1000Research2046-14022020-06-01910.12688/f1000research.21100.123223Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]Nicholas Liaw0David Liebeskind1Department of Vascular Neurology, University of California, Los Angeles, 635 Charles E Young Drive South, Suite 225, Los Angeles, California, 90095-7334, USADepartment of Vascular Neurology, University of California, Los Angeles, 635 Charles E Young Drive South, Suite 225, Los Angeles, California, 90095-7334, USAThrombolysis and mechanical thrombectomy have revolutionized the care of patients with acute ischemic stroke. The number of patients who can benefit from these treatments continues to increase as new studies demonstrate that not just time since stroke onset but also collateral circulation influences outcome. Technologies such as telestroke, mobile stroke units, and artificial intelligence are playing an increasing role in identifying and treating stroke. Stroke-systems-of-care models continue to streamline the delivery of definitive revascularization in the age of mechanical thrombectomy.https://f1000research.com/articles/9-546/v1 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nicholas Liaw David Liebeskind |
spellingShingle |
Nicholas Liaw David Liebeskind Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved] F1000Research |
author_facet |
Nicholas Liaw David Liebeskind |
author_sort |
Nicholas Liaw |
title |
Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved] |
title_short |
Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved] |
title_full |
Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved] |
title_fullStr |
Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved] |
title_full_unstemmed |
Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved] |
title_sort |
emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved] |
publisher |
F1000 Research Ltd |
series |
F1000Research |
issn |
2046-1402 |
publishDate |
2020-06-01 |
description |
Thrombolysis and mechanical thrombectomy have revolutionized the care of patients with acute ischemic stroke. The number of patients who can benefit from these treatments continues to increase as new studies demonstrate that not just time since stroke onset but also collateral circulation influences outcome. Technologies such as telestroke, mobile stroke units, and artificial intelligence are playing an increasing role in identifying and treating stroke. Stroke-systems-of-care models continue to streamline the delivery of definitive revascularization in the age of mechanical thrombectomy. |
url |
https://f1000research.com/articles/9-546/v1 |
work_keys_str_mv |
AT nicholasliaw emergingtherapiesinacuteischemicstrokeversion1peerreview3approved AT davidliebeskind emergingtherapiesinacuteischemicstrokeversion1peerreview3approved |
_version_ |
1724466331881832448 |